Skip to contentE
Escalon Medical Corp
E
ESMCEscalon Medical Corp Q3 2025 · 10-Q
Revenue$3.47M$3.47M+28.9% vs Q3 2024 Net Income$271.47K$271.47KN/M vs Q3 2024 EPS Diluted$0.02$0.02N/M vs Q3 2024 Operating Income$276,037N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Escalon Medical Corp · CIK 862668 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$30,695−83.4% Margins · derivedOperating margin7.9%+13.8 pt vs Q3 2024
Net margin7.8%+13.8 pt vs Q3 2024
ended Mar 31, 2025 · filed May 14, 2025 · 44 d after period end